The potential role of tau protein O-glycosylation in Alzheimer's disease

J Alzheimers Dis. 2004 Oct;6(5):489-95. doi: 10.3233/jad-2004-6505.

Abstract

Single O-linked N-acetylglucosamine (O-GlcNAc) sugar residues can compete with phosphate groups to occupy specific sites on certain nuclear and cytosolic proteins. Here we show that inhibiting cellular kinase activities resulted in changes in protein O-glycosylation levels in heat-stable cytoskeletal protein fractions derived from primary neuronal cells. As increased phosphorylation of the microtubule-associated protein tau is one of the pathological hallmarks of Alzheimer's disease and glycosylation may play an influential role in this process. We observed a significant decrease in the protein O-GlcNAc glycosylation of a tau-enriched cytoskeletal fraction generated from AD post-mortem brain samples as compared with control, suggesting an inverse relationship between the two post-translational modifications. Finally, cells transfected with the cDNA coding for O-GlcNAc transferase (OGT) displayed altered tau phosphorylation patterns as compared with control cells, suggesting that changes in tau glycosylation may influence its phosphorylation state. The specificity of the changes in the phosphorylation of individual amino acid residues provides evidence for a targeted O-glycosylation of tau.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Blotting, Western
  • Dementia / metabolism
  • Frontal Lobe / metabolism
  • Frontal Lobe / pathology
  • Glycosylation*
  • Humans
  • Nerve Tissue Proteins / metabolism*
  • Neurofibrillary Tangles / metabolism
  • Neurofibrillary Tangles / pathology
  • Sensitivity and Specificity
  • Temporal Lobe / metabolism
  • Temporal Lobe / pathology
  • tau Proteins

Substances

  • MAPT protein, human
  • Nerve Tissue Proteins
  • tau Proteins